Filing Details
- Accession Number:
- 0001209191-12-055401
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-03 17:47:44
- Reporting Period:
- 2012-11-29
- Filing Date:
- 2012-12-03
- Accepted Time:
- 2012-12-03 17:47:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1333170 | Nxstage Medical Inc. | NXTM | Electromedical & Electrotherapeutic Apparatus (3845) | 043454702 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1341407 | S David Utterberg | C/O Nxstage Medical, Inc. 350 Merrimack Street Lawrence MA 01843 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-11-29 | 21,346 | $12.13 | 4,300,950 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-11-30 | 19,973 | $11.99 | 4,280,977 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-12-03 | 26,325 | $12.06 | 4,254,652 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2010, amended on March 11, 2011, and further amended on August 15, 2012.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.22. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.54 to $12.06. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.89 to $12.15. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
Billionaire Hedge Funds
